[11 March 2013]
Products Affected - Description
Bacteriostatic sodium chloride 0.9% vials
Reason for the Shortage
- APP had bacteriostatic sodium chloride 0.9% vials on shortage due to increased demand for the product.
- Hospira had bacteriostatic sodium chloride 0.9% vials on shortage due to manufacturing delays.
Bacteriostatic sodium chloride 0.9% vials, APP
10 mL plastic vials (NDC 63323-0924-10)
30 mL plastic vials (NDC 63323-0924-30)
30 mL glass vials (NDC 63323-0259-30)
Bacteriostatic sodium chloride 0.9% vials, Hospira
10 mL plastic vials (NDC 00409-1966-12)
20 mL plastic vials (NDC 00409-1966-05)
30 mL plastic vials (NDC 00409-1966-07)
Estimated Resupply Dates
APP and Hospira have bacteriostatic sodium chloride 0.9% injection available.
March 11, 2013; February 26, 2013; January 28, 2013; January 3, 2013; December 10, 2012; November 30, 2012; November 13, 2012; November 9, 2012; November 2, 2012; October 17, 2012; September 27, 2012; September 10, 2012; August 29, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins